logo
Second strain of bird flu found in Nevada dairy cows

Second strain of bird flu found in Nevada dairy cows

The Hill06-02-2025
Dairy cows in Nevada have been infected with a new strain of bird flu virus different from the one circulating in other herds throughout the past year, the U.S. Department of Agriculture (USDA) said.
The strain found in the Nevada cattle raises new questions about the spread of the avian influenza virus in dairy cows, which many assumed began after the virus jumped from birds in Texas.
The newer version of the virus matches the strain currently found in wild birds and domestic poultry, as well as in the severe human cases — a Louisiana man who died in January, and a Canadian teen who was hospitalized for more than two months and nearly died.
The virus has never before been seen in cattle, ruling out the possibility that the Nevada cows caught it from another infected herd.
Michael Worobey, an evolutionary biologist at the University of Arizona, said the initial hope was that a rare mutation allowed the virus to jump from birds and settle in cattle.
'Now, we know that's not true,' Worobey said. 'It means that we might be playing Whack-a-Mole with it just jumping in over and over again, and the tools that we hoped to use to get rid of [the virus] might not work as well.'
This is also the second known instance of cattle becoming infected after the virus jumped from wild birds, which experts said shows that cattle are susceptible to other H5N1 viruses, not just the specific subtype that started in Texas and has since infected 950 dairy herds in 16 states, according to USDA.
'Right now it's unclear how widespread this is. But given D1.1's prevalence in wild and domestic birds right now, we should be aggressively testing exposed dairy cattle who are near H5 positive poultry premises to see whether this phenomenon is present beyond Nevada,' Louise Moncla, a pathobiologist at the University of Pennsylvania, said in an email.
But since testing has not been very thorough in many states, given the reluctance of farmers to get their herds tested, it's possible there have been other undetected instances of the virus spilling over from birds to cattle.
The USDA said the detection of this version of the virus was confirmed Jan. 31 after it was found in raw milk collected from a silo as part of a national milk testing strategy that started in 2024.
Federal officials have maintained there is a low risk to the general public, and experts said there doesn't appear to be a change based on the new findings.
But Moncla also noted the human cases associated with exposure to infected cattle have been mild, while at least one severe case has come after exposure to wild birds or backyard flocks.
'Though it's too soon to make any conclusions about this, it is concerning. We don't yet know if these viruses are better at infecting people. But if they are, then introduction into dairy cattle could enhance human exposure risk,' Moncla said.
Worobey said he is leading a team of scientists to try to find out how long the latest strain was circulating in cattle before it was discovered. But he said the finding diminishes the prospect that the virus could be eliminated from cattle entirely, because it was such a different version of the virus that made the jump from birds into cattle.
The immunity built up in the dairy cattle population against bird flu may not hold up well against the D1.1 genotype.
'The cattle might have to start fresh in terms of building up immunity to this strain as well,' Worobey said.
There are also concerns about potential vaccines, and if they are so specific to the first variant that they're not going to help block transmission of the new variant.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

This High-Yield Dividend Stock Is Staging a Comeback. Should You Buy Shares Now?
This High-Yield Dividend Stock Is Staging a Comeback. Should You Buy Shares Now?

Yahoo

time34 minutes ago

  • Yahoo

This High-Yield Dividend Stock Is Staging a Comeback. Should You Buy Shares Now?

When a 'boring' healthcare stock posts a 7% surge intraday, investors take notice. That's exactly what happened when CVS Health delivered its second-quarter 2025 earnings on July 31. The healthcare giant's adjusted earnings of $1.81 per share crushed analyst estimates of $1.45, while revenue climbed 8.4% year-over-year to $98.92 billion. This impressive beat comes at a time when the S&P 500 Healthcare Index ($SRHC) fell 12% over the past year, significantly trailing the broader S&P 500 Index's ($SPX) gain of 18.2%. CVS itself endured a particularly volatile 2024, cutting its earnings guidance three times and watching its stock plummet over 40% as medical costs in its Aetna insurance division spiraled higher than expected. More News from Barchart This Blue-Chip Dividend Stock Is Stuck in the Tariff Crosshairs. Can Cost Cuts Save the Day? Worried About a Stock Market Crash? These Dividend Stocks Can Help You Ride It Out Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! Yet, with its latest results stirring up fresh optimism, it's worth asking - is this high-yield dividend stock at the start of a legitimate comeback, or was the Q2 surprise - like last Thursday's intraday rally - just a fleeting moment of glory? Let's dive in. CVS's Latest Q2 Financial Results CVS Health (CVS), a retail pharmacy, healthcare services, and insurance company, boasts a market capitalization of approximately $79 billion. The company's high-yield credentials are anchored by a robust annual dividend rate of $2.66, delivering shareholders an above-market dividend yield of 4.26%, and elevating CVS into the upper echelon of dividend stocks. Shares have surged 37.1% year-to-date, but CVS stock trades at just 10.05x forward adjusted earnings - a generous discount to the healthcare sector median of 16.86x - and boasts a similarly low price/earnings-to-growth (PEG) ratio of only 0.59x. This lower multiple suggests the market still underappreciates CVS's earnings momentum and long-term growth prospects. In the July 31 Q2 report, total revenues climbed to $98.9 billion, marking an 8.4% year-over-year gain that eclipsed analysts' forecasts. While second-quarter GAAP diluted EPS landed at $0.80, down from $1.41 a year earlier, this was mainly due to two significant litigation charges tied to legacy business issues. Perhaps more importantly, management reported $6.5 billion in cash flow from operations year-to-date, reinforcing both dividend security and strategic agility. The company's earnings power is being driven by improved performances in its Health Care Benefits and Pharmacy & Consumer Wellness segments, offsetting short-term headwinds in Health Services. CVS's Next Strategic Act CVS inked a pivotal deal with Rite Aid, agreeing to acquire select prescription files and store locations across 15 states. This acquisition stands to significantly broaden CVS's market reach while promising meaningful operational synergies. This could be a crucial lever as CVS aims to build scale and streamline retail pharmacy operations at a time when consumer patterns are evolving fast. In another move to future-proof its business, CVS Health committed a staggering $20 billion investment over the next decade to overhaul healthcare delivery, with a focus on harnessing advanced technology and achieving real interoperability across its ecosystem. This is a long-term wager on connecting care in ways that competitors haven't matched. May 2025 brought another headline-worthy shift: CVS Caremark struck an exclusive partnership with Novo Nordisk (NVO), designating Wegovy as the preferred GLP-1 weight loss drug on all Caremark standard formularies starting July 1. This decision impacts tens of millions of Caremark beneficiaries and, at the same time, removes Eli Lilly's (LLY) Zepbound from CVS's standard list. CVS Pharmacy is now also the inaugural retail pharmacy in Novo's NovoCare network, offering the in-demand Wegovy at a sharply competitive $499 per month for cash-paying customers across all 9,000 CVS locations. Analysts' Consensus on CVS The average consensus among Wall Street analysts is strikingly bullish, forecasting earnings per share of $1.42 for the current quarter, up sharply from $1.09 a year ago, and $6.37 for the full fiscal year, compared to $5.42 last year. That's a growth rate estimate of +30.28% for the quarter and +17.53% for the year,. Backing up this optimism, CVS management hiked its outlook, boosting the full-year adjusted EPS guidance to a range of $6.30 to $6.40 from a prior $6.00 to $6.20. At the same time, the company expects at least $7.5 billion in operating cash flow, up from its earlier $7.0 billion forecast, and offered refined GAAP diluted EPS guidance between $3.84 and $3.94. Perhaps most compelling for prospective investors, nearly three-quarters of the 23 analysts in coverage rate CVS a 'Strong Buy.' The mean analyst price target is $79.41, pointing to a promising 29.2% upside potential from CVS's current price. Conclusion With the majority of analysts labeling CVS a 'Strong Buy' and nearly 30% upside baked into price targets, it's hard to ignore the opportunity here. CVS checks the boxes for value, growth, and high yield, all wrapped in a comeback narrative the market loves. At current levels, the stock could be a compelling value pick for yield hunters as its turnaround gains traction. However, given its placement across policy-sensitive sectors like healthcare and insurance, investors should be prepared for potential headline-driven volatility along with that passive income. On the date of publication, Ebube Jones did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on

Colorado first blue state to have SNAP waiver approved limiting soda
Colorado first blue state to have SNAP waiver approved limiting soda

The Hill

timean hour ago

  • The Hill

Colorado first blue state to have SNAP waiver approved limiting soda

Colorado is the first blue state to have a waiver approved for the Supplemental Nutrition Assistance Program (SNAP) that limits the ability to buy soda and other sugary beverages, set to go into effect in March 2026. 'Colorado is one of the healthiest states in the nation and has the lowest obesity rate of any state. Sadly, even Colorado's lowest obesity rate of 24.9% is too high, and obesity endangers and shortens the lives of too many Coloradans,' Colorado Gov. Jared Polis (D) said in a Monday release from the U.S. Department of Agriculture (USDA). 'Today's waiver is a big step towards improving the health of Coloradans, and reducing obesity rates, diabetes, and tooth decay,' he added. Agriculture Secretary Brooke Rollins signed Colorado's waiver, along with the waivers for states like Florida and Louisiana on Monday. 'SNAP is a supplemental nutrition program meant to provide health food benefits to low-income families to supplement their grocery budget so they can afford the nutritious food essential to health and well being,' Rollins said Monday before signing the waivers. 'That is the stated purpose of the SNAP program, the law states it and President Trump's USDA plans to deliver on it,' she added. President Trump's recently-signed 'big, beautiful bill,' which the president aggressively pushed across the finish line last month, cuts tens of millions of dollars from SNAP as well as close to $1 trillion in federal medicaid spending.

Canadian wildfires spark NY air-quality alert: ‘Can pose serious health risks'
Canadian wildfires spark NY air-quality alert: ‘Can pose serious health risks'

New York Post

time3 hours ago

  • New York Post

Canadian wildfires spark NY air-quality alert: ‘Can pose serious health risks'

Canadian wildfires may be posing 'serious health risks'' to people in New York — prompting an air-quality alert for the state through Monday and a warning for some regions into Tuesday. The metro area's current ailing air quality and hazy skies are hampering the five boroughs, Long Island, Hudson Valley, Adirondacks, eastern Lake Ontario and Central and Western New York regions, according to an alert issued Monday by Gov. Kathy Hochul. Canadian wildfires cloak Manhattan in haze last month. Luiz C. Ribeiro for New York Post Advertisement Pollution from fine particulate matter fueled by the wildfires is expected to push the local Air Quality Index past 100, meaning it will be unhealthy for sensitive groups, including children, older adults and people with heart or lung conditions. In some areas, the index could go above 150 momentarily. The tiny particles can cause eye, nose, and throat irritation along with coughing, sneezing and shortness of breath. They can also worsen asthma and heart disease. Advertisement 'New York continues to track air quality conditions across the state, and people in certain areas may notice visible smoke throughout the day,' Hochul said in a statement. The advisory remains in effect through 11:59 p.m. Monday, but weather patterns are anticipated to bring more spikes in smoke in certain regions across the state Tuesday. Wildfires destroy scores of acres in British Columbia. AP Officials urged everyone in sensitive groups to check their local Air Quality Index and take precautions, including limiting outdoor activity. Advertisement 'Poor air quality can pose serious health risks — especially for those with heart conditions, lung diseases, such as asthma, young children, those over 65 years old, and pregnant individuals,' New York Health Commissioner Dr. James McDonald said in a statement. 'To reduce exposure, limit strenuous activity outdoors.' The smoky situation is just the latest to cloud city skies this year. Multiple alerts were issued in June when ozone pollution and wildfire haze from Canada triggered warnings across the tri-state area. Advertisement More than 700 active wildfires are currently blazing across Canada, with roughly two-thirds of them still out of control, according to the Canadian Interagency Forest Fire Center.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store